RFK Jr is to open US access to unapproved peptide injections despite opposition from most of his own FDA scientists

Robert F. Kennedy Jr. is set to direct the FDA not to pursue enforcement action against specialty pharmacies selling certain injectable peptides — including BPC-157 and TB-500 — that have never been approved for human use. The draft policy, driven by Kennedy's Department of Health and Human Services, is at the final stage of White House regulatory review before publication. Most FDA scientific staff opposed the plan, warning it would undermine the agency's core mission of keeping unproven products off the market.

Kennedy has called himself a 'big fan' of peptides; international sports authorities classify both BPC-157 and TB-500 as banned doping substances.